SDHA and ovarian cancer: We also expanded our panel of genetically engineered human ovarian cancer cell lines with conditional (dox inducible) SDHA overexpression (SDHA-OE) or stable SDHA knockdown (KD), as well as established human fallopian tube cell lines (FT190 and FT194) as controls (Figure 1C,D and Supplementary Figure S1H).